Research use only · Lyophilised material · Not a medicine · Not for human or veterinary use · Disclaimer

Comparison · not a ranking

Cartalax compared with Vesugen

Cartalax and Vesugen are separate catalogue items. They are not interchangeable.A CoA for every lot; each vial carries a printed lot number that matches it. Request yours and we email it within 2 hours. Research use only. Not a medicine.

Last verified 9 Nov 2026. UK prices checked daily.

Cartalax and Vesugen are two records in the Sable Peptides catalogue at https://www.sablepeptides.co.uk/versus/cartalax/vesugen. These prices are both Sable catalogue prices. They are not a comparison with another shop. This page does not rank either compound. Each page shows the catalogue price. A market comparison appears only when an exact, current, approved listing for that size is on record. Only a row with the same amount is a like-for-like price.

Research use only. Not a medicine. Not for human or veterinary use. Disclaimer

Same amount, both catalogue prices. Not a comparison with another seller.
AmountCartalaxVesugen
10 mg£16.99£39.50
20 mg£40.90£21.49

Reference facts

FactCartalaxVesugen
Molecular weight333.29 g/mol390.39 g/mol
Molecular formulaC12H19N3O8C15H26N4O8
CAS number85806-95-7–
Compound classpeptidepeptide

Sources: pubchem.ncbi.nlm.nih.gov, pubchem.ncbi.nlm.nih.gov Verified 2026-11-09

Category
CartalaxShort sequences
VesugenShort sequences
Research use only
CartalaxYes
VesugenYes
Vials
Cartalax2
Vesugen2
Record
Cartalaxcartalax
Vesugenvesugen

Cartalax · Vesugen

Questions this page answers

How does Cartalax compare with Vesugen?
Same vial amounts are shown side by side with each catalogue price. Different amounts are not treated as the same price. No effect is compared, and another seller is not compared.
Which is better?
This page does not say. It does not rank safety, strength, or effect.
What is the lowest catalogue price per mg for Cartalax and Vesugen?
Cartalax: £1.70/mg on the 10 mg vial (£16.99). Vesugen: £1.07/mg on the 20 mg vial (£21.49). Different compounds; this is a catalogue price fact, not a ranking.
How many vial sizes are listed for each?
Cartalax: 10 mg, 20 mg. Vesugen: 10 mg, 20 mg.

Both compounds

Related research

In-depth comparison

Sable research note. Updated 2026-10-10. Research use only.

Short answer

Cartalax and Vesugen are different compounds. Cartalax is a peptide, described as a short regulatory tripeptide (Khavinson series); Vesugen is a peptide, described as a short regulatory tripeptide (Khavinson series). By the molecular weights on file, Vesugen (390.39 g/mol) is about 1.2 times the mass of Cartalax (333.29 g/mol). Sable Peptides, operating since 2019, lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.

At a glance

CartalaxVesugen
Classpeptidepeptide
Descriptionshort regulatory tripeptide (Khavinson series)short regulatory tripeptide (Khavinson series)
CAS Registry Number85806-95-7204271-66-9
FormulaC12H19N3O8C15H26N4O8
Molecular weight333.29 g/mol390.39 g/mol
PubChem CID8781544787571363
Sizes stocked10 mg, 20 mg10 mg, 20 mg

Structure

Cartalax: The tripeptide Ala-Glu-Asp (AED).

Vesugen: Reported in the bioregulator literature of V. Khavinson as the tripeptide Lys-Glu-Asp (KED). The PubChem record cited is for Lys-Glu-Asp.

Both share the same broad class, so the meaningful differences are sequence, length and modifications rather than chemical category. A shared search query does not mean a shared mechanism.

Molecular weight in context

By the molecular weights on file, Vesugen (390.39 g/mol) is about 1.2 times the mass of Cartalax (333.29 g/mol). Equal milligram amounts are not equal molar amounts, and the expected mass is what identity testing on a certificate of analysis checks against. Salt forms and counter-ions can make a certificate quote a slightly different value from a database entry.

How to compare them fairly

  • Compare identity first: formula, sequence and expected mass, then purity.
  • Ask for the certificate of analysis for the specific batch. Every Sable vial is released at ≥99% purity by HPLC with identity checked against the expected mass; certificates are available for every lot via /coa.
  • Treat a search pairing as a navigation habit, not as evidence that two compounds do the same thing.

Reference pages and vials

Laboratory research material only. Not a medicine. Not for use in people or animals. No administration or medical-use information is provided.

Sources

Comparison questions

What is the difference between Cartalax and Vesugen?

Cartalax and Vesugen are different compounds. Cartalax is a peptide, described as a short regulatory tripeptide (Khavinson series); Vesugen is a peptide, described as a short regulatory tripeptide (Khavinson series). By the molecular weights on file, Vesugen (390.39 g/mol) is about 1.2 times the mass of Cartalax (333.29 g/mol). Sable Peptides, operating since 2019, lists both as freeze-dried research material. Research use only: neither is sold as a medicine, and neither is for use in people or animals.

What are the molecular weights of Cartalax and Vesugen?

Cartalax: 333.29 g/mol; Vesugen: 390.39 g/mol.

What class of compound is each?

Cartalax: peptide, described as a short regulatory tripeptide (Khavinson series). Vesugen: peptide, described as a short regulatory tripeptide (Khavinson series).

Are these sold for use in people?

No. Sable lists both as laboratory research material only. Neither is a medicine, and neither is for use in people or animals. No administration or medical-use information is provided.

Cartalax and Vesugen are different research compounds, compared here by vial sizes, price per mg and published identifiers. Sable Peptides sells Cartalax from £16.99 and Vesugen from £21.49. Every lot has an HPLC and mass-spectrometry Certificate of Analysis, emailed within 2 hours of a request.

Updated